Clinical trial
Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild…
NCT00483899 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00483899 |
|---|---|
| Title | Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects |
| Official title | Double-blind, Placebo-controlled, 3-way Crossover Study to Investigate the Effect of 7-days Repeat Once Daily Inhaled Doses of GW870086X Administered Via DISKHALER on Airway Responsiveness to AMP in Mild Steroid-naive Male Asthmatics |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | GW870086X, Placebo |
| Enrollment | 20 |
| Start date | Oct 7, 2005 |
| Primary completion | Dec 15, 2006 |
| Completion | Dec 15, 2006 |
| First posted | Jun 7, 2007 |
| Last update posted | Sep 29, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: